Nephrol Dial Transplant (2001) 16: 373-377
© 2001 European Renal Association-European Dialysis and Transplant Association
Effect of grapefruit juice on Sandimmun Neoral® absorption among stable renal allograft recipients
Department of Nephrology Y, Odense University Hospital, Odense, Denmark
Background. The oral formulation of cyclosporin A (CsA)—Sandimmun—has a highly variable absorption. The development of a CsA microemulsion—Sandimmun Neoral—resulted in increased bioavailability, and decreased variability of absorption. The first oral formulation (Sandimmun) interacted with numerous other drugs and grapefruit juice. Several of these interactions might be explained by decreased pre-systemic metabolism by a cytochrome-enzyme (e.g. CYP3A4) located in the enteral mucosa, and/or via the P-glycoprotein-mediated decreased transport of CsA back from enterocytes into the gut lumen. The purpose of this pharmacokinetic study was to investigate the interaction between Sandimmun Neoral and grapefruit juice.
Method. Eight stable renal transplant recipients were studied during two 8-h sessions in a randomized cross-over design with 4 weeks interval. Following an overnight fast the patients ingested their habitual morning dose of Neoral either with water or with grapefruit juice. During the 8-h study period 10 blood samples were taken for determination of CsA concentration. These results formed the basis for calculation of area under curve (AUC), and half-life (t
). Maximum concentration (Cmax) and time until Cmax (tmax) were obtained from the concentration–time profile.
Results. The median AUC increased by 38% (12–194%) (P<0.05) following co-administration of Neoral with grapefruit juice. There were no significant changes in Cmax, tmax, and t.
Conclusion. Co-administration of Sandimmun Neoral with grapefruit juice resulted in an increased bioavailability of CsA, indicating unchanged pre-systemic enterocyte first-pass metabolism as compared to Sandimmun. There was no impact of an oral grapefruit juice load on systemic clearance of CsA. It seems prudent to advise renal allograft recipients treated with Sandimmun Neoral not to ingest their medication with grapefruit juice.
Keywords: absorption; cyclosporin A; grapefruit juice; interaction; Sandimmun Neoral
Correspondence and offprint requests to: Claus Bistrup MD, Department of Nephrology Y, Odense University Hospital, DK-5000 Odense C, Denmark.
E-mail: Claus.Bistrup{at}dadlnet.dk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. S. Joy, M. La, and Bo Xiao Individualizing Therapy in Patients With Chronic Kidney Disease Journal of Pharmacy Practice, June 1, 2008; 21(3): 225 - 236. [Abstract] [PDF]
|
|
|
|
 |
|
 M. F Paine, W. W Widmer, S. N Pusek, K. L Beavers, A. B Criss, J. Snyder, and P. B Watkins Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine Am. J. Clinical Nutrition, April 1, 2008; 87(4): 863 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. U. Mertens-Talcott, I. Zadezensky, W. V. De Castro, H. Derendorf, and V. Butterweck Grapefruit-drug interactions: can interactions with drugs be avoided? J. Clin. Pharmacol., December 1, 2006; 46(12): 1390 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rheeders, M. Bouwer, and T. C. Goosen Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine. J. Clin. Pharmacol., July 1, 2006; 46(7): 768 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Bergman, J. Burke, P. Larson, A. O. Johnson-Levonas, L. Reyderman, P. Statkevich, T. Kosoglou, H. E. Greenberg, W. K. Kraft, G. Frick, et al. Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects. J. Clin. Pharmacol., March 1, 2006; 46(3): 321 - 327. [Abstract] [Full Text] [PDF]
|
|